Author

Pascal Irrgang

Friedrich-Alexander-Universität Erlangen-NürnbergORCID 0000-0003-2829-6096Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:non-human primate· 1

Frequent Co-Authors

Berit RoshaniiD· 1 shared Christiane Stahl‐HennigiD· 1 shared Dennis LapuenteiD· 1 shared Edmond J. RemarqueiD· 1 shared Gerrit KoopmaniD· 1 shared Ivanela I. KondovaiD· 1 shared Klaus ÜberlaiD· 1 shared Matthias TenbuschiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Berit RoshaniORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A confirmatory, dual-centric non-human primate study on the efficacy of novel oropharyngeal spray immunization with an adenoviral vector vaccine against RSV -- Important lessons learned

Matthias Tenbusch, Gerrit Koopman, Petra Mooij, Berit Roshani, Pascal Irrgang, Dennis Lapuente, Ivanela I. Kondova, Willy M J M Bogers, Edmond J. Remarque, Ramona Vestweber, Samuel Alberto Mérida Ruíz, Nadine Krüger, S Meyer, Olaf Gefeller, Christiane Stahl‐Hennig, Klaus Überla

This study evaluates a DNA-adenoviral prime-boost vaccine for RSV in non-human primates, showing reduced viral replication but challenges in multi-centre trials.

bioRxiv · Apr 20, 2026 · PreprintImmunology